ARG57062

anti-ADSL / Adenylosuccinate Lyase antibody [16C10]

anti-ADSL / Adenylosuccinate Lyase antibody [16C10] for Flow cytometry,Western blot and Human

Overview

Product Description Mouse Monoclonal antibody [16C10] recognizes ADSL / Adenylosuccinate Lyase
Tested Reactivity Hu
Tested Application FACS, WB
Host Mouse
Clonality Monoclonal
Clone 16C10
Isotype IgG1, kappa
Target Name ADSL / Adenylosuccinate Lyase
Antigen Species Human
Immunogen Recombinant fragment around aa. 1-484 of Human ADSL / Adenylosuccinate Lyase.
Conjugation Un-conjugated
Alternate Names ASASE; ASase; EC 4.3.2.2; Adenylosuccinase; Adenylosuccinate lyase; AMPS; ASL

Application Instructions

Application Suggestion
Tested Application Dilution
FACSAssay-dependent
WBAssay-dependent
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Purification with Protein A.
Buffer PBS (pH 7.4), 0.02% Sodium azide and 10% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 10% Glycerol
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 158 Human ADSL

Swiss-port # P30566 Human Adenylosuccinate lyase

Gene Symbol ADSL
Gene Full Name adenylosuccinate lyase
Background Adenylsuccinate lyase is involved in both de novo synthesis of purines and formation of adenosine monophosphate from inosine monophosphate. It catalyzes two reactions in AMP biosynthesis: the removal of a fumarate from succinylaminoimidazole carboxamide (SAICA) ribotide to give aminoimidazole carboxamide ribotide (AICA) and removal of fumarate from adenylosuccinate to give AMP. Adenylosuccinase deficiency results in succinylpurinemic autism, psychomotor retardation, and , in some cases, growth retardation associated with muscle wasting and epilepsy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Function Catalyzes two non-sequential steps in de novo AMP synthesis: converts (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate (SAICAR) to fumarate plus 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide, and thereby also contributes to de novo IMP synthesis, and converts succinyladenosine monophosphate (SAMP) to AMP and fumarate. [UniProt]
Calculated MW 55 kDa

Images (2) Click the Picture to Zoom In

  • ARG57062 anti-ADSL / Adenylosuccinate Lyase antibody [16C10] FACS image

    Flow Cytometry: Hep3B cell line stained with ARG57062 anti-ADSL / Adenylosuccinate Lyase antibody [16C10] at 2-5 µg for 1x10^6 cells (red line). Secondary antibody: Goat anti-Mouse IgG Alexa fluor 488 conjugate. Isotype control antibody was Mouse IgG (black line).

  • ARG57062 anti-ADSL / Adenylosuccinate Lyase antibody [16C10] WB image

    Western blot: 1) 20 ng of Recombinant Protein, 40 µg of 2) HeLa cell lysate, 3) 293T cell lysate, 4) Jurkat cell lysate, 5) HepG2 cell lysate, 6) A549 cell lysate, and 7) MCF7 cell lysate stained with ARG57062 anti-ADSL / Adenylosuccinate Lyase antibody [16C10] at 1:1000.